№ lp_1_2_22070
File format: docx
Character count: 27951
File size: 4342 KB
The document is a teaching resource designed for Science Stage 5, providing a learning sequence focused on investigating the reaction between magnesium metal and hydrochloric acid, including detailed instructions for conducting experiments and writing scientific reports.
Year:
2022
Region / city:
New South Wales, Australia
Theme:
Science, Chemistry
Document type:
Teaching Resource
Organization / Institution:
NSW Education Standards Authority
Author:
N/A
Target audience:
Teachers, students (Science Stage 5)
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Topic:
HIV Diagnosis, Linkage to Care, and Prevention Services
Document Type:
Guide
Organization / Institution:
CDC
Target Audience:
HIV-positive individuals who participated in the GAIN study
Note:
Year
Subject:
Chemical Safety, Laboratory Procedures
Document Type:
Standard Operating Procedure (SOP)
Target Audience:
Laboratory Personnel
Year:
2023
Region / City:
United States
Subject:
Chemical Safety
Document Type:
Standard Operating Procedure (SOP)
Organization / Institution:
WSU
Author:
Not specified
Target Audience:
Laboratory staff, researchers
Effective Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Hazard Statements
Year:
2022
Region / City:
United States
Subject:
Environmental Protection, Lead Acid Battery Manufacturing
Document Type:
Regulatory Proposal
Organization / Institution:
Environmental Protection Agency (EPA)
Author:
Environmental Protection Agency
Target Audience:
Owners and operators of lead acid battery manufacturing plants
Period of Validity:
N/A
Approval Date:
February 2022
Date of Amendments:
February 27, 2014
Year:
2024
Region / city:
Australia
Topic:
Medical Research, Stroke, Cerebral Amyloid Angiopathy, Clinical Trial
Document Type:
Participant Information Sheet / Consent Form
Organization / institution:
Alfred Health
Author:
Dr. Oshi Swarup, Prof Geoffrey Cloud, Prof Nawaf Yassi
Target Audience:
Adults with Cerebral Amyloid Angiopathy
Period of Action:
26 weeks
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
N/A
Region / City:
N/A
Topic:
HIV Diagnosis, HIV Prevention
Document Type:
Survey
Organization / Institution:
CDC
Author:
N/A
Target Audience:
Participants of the GAIN Study
Effective Period:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Version:
HNY v2.0
Replaces version:
HNY v1.0
Clinical content last reviewed:
November 2023
Next review date:
April 2028
Note:
RDTC v1.0 8th March 2024
Local review and adoption:
September 2025
Approved for use by HNY ICB:
1st October 2025
Clinical content reviewed and updated by RDTC:
November 2023
Year:
2025
Region / City:
UK
Topic:
Healthcare, Medication Guidelines
Document Type:
Medical Protocol
Organisation:
National Ambulance Service Medical Directors (NASMeD)
Author:
Dr. Elizabeth Miller, Dr. Dave Macklin, Mr. Andy Curran, Rosie England, Cathryn James, Dan Haworth, Tracy Rogers, Jo Jenkins, Rosie Furner
Target Audience:
Registered healthcare professionals, Paramedics, Nurses, Midwives
Effective Date:
May 2023
Review Date:
October 2025
Expiry Date:
April 2026
Approval Date:
May 2025
Change History:
Includes updates to drug administration protocols and clinical guidelines
Note:
Year
Background:
The submission requested a General Schedule Authority Required (Telephone/Online) listing of a new form of adrenaline (epinephrine) acid tartrate 150 micrograms/0.15 mL autoinjector (AI) (Jext® Junior (Jr)) and 300 micrograms/0.3 mL AI (Jext®) under the same circumstances as the currently listed adrenaline (epinephrine) 150 microgram/0.3 mL AI (EpiPen® Jr and Anapen® Jr 150) and 300 microgram/0.3 mL AI (EpiPen® and Anapen® 300).
Year:
2019
Region / city:
Australia
Topic:
Medical device, eye care
Document type:
Public Summary Document
Organ / institution:
Therapeutic Goods Administration (TGA), Pharmaceutical Benefits Advisory Committee (PBAC)
Author:
Allergan Australia Pty Ltd
Target audience:
Healthcare professionals, medical practitioners
Period of validity:
Not specified
Approval date:
13 March 2019
Date of amendments:
Not specified
Year:
2026
Region / City:
Gainesville, FL
Topic:
Chemical Safety
Document Type:
Safety Procedure
Organization / Institution:
University of Florida
Author:
Environmental Health & Safety (EH&S)
Target Audience:
Laboratory Personnel
Effective Period:
Indefinite
Approval Date:
2026-02-07
Review Date:
Every 2 years
Revision Date:
N/A
Description:
A standard operating procedure detailing safety precautions, training requirements, and emergency contact information for laboratory use of hydrofluoric acid.
Year:
2023
Region / city:
Australia
Topic:
Chemical pollutants
Document type:
Technical report
Organization / institution:
Stockholm Convention
Author:
Unknown
Target audience:
Environmental scientists, regulators
Effective period:
Ongoing
Approval date:
Unknown
Date of amendments:
Unknown
Context:
A technical report on the environmental and health impacts of PFOA chemicals, detailing their historical use, regulatory status, and risks.
Note:
Year
Subject:
Biosafety, Recombinant Nucleic Acids, Synthetic Nucleic Acids, Biohazardous Materials
Document Type:
Registration Form
Institution:
Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s Hospital of Chicago
Target Audience:
Researchers conducting experiments involving recombinant or synthetic nucleic acids or biohazardous materials
Year:
2023
Region / City:
International
Topic:
Nucleotide and amino acid sequence listings
Document type:
Standard
Organization / Institution:
SEQL Task Force
Audience:
Patent offices, applicants, and patent examiners
Period of validity:
Indefinite
Approval date:
Not provided
Date of amendments:
Not provided
Year:
2024
Region / City:
New South Wales, Australia
Subject:
English Studies
Document Type:
Curriculum Scope and Sequence
Author:
New South Wales Education Standards Authority (NESA)
Target Audience:
Teachers of English Studies Year 11–12 in NSW
Effective Period:
2024–2025
Approval Date:
2024
Revision Date:
2025
Year:
2026
Region / city:
Australia
Subject:
Mathematics
Document Type:
Educational resource
Organization:
NESA
Audience:
Teachers, Students
Period:
Year 11-12
Approval Date:
N/A
Modification Date:
N/A
Year:
2024
Region / city:
New South Wales, Australia
Topic:
Aboriginal Studies curriculum
Document Type:
Educational resource
Organization:
NSW Education Standards Authority (NESA)
Author:
N/A
Target audience:
Teachers, educators, curriculum developers
Period of validity:
2024
Date of approval:
2024
Date of changes:
N/A
Document symbol:
CBD/WGDSI/2/2/Add.2/Rev.1
Distribution:
General
Original language:
English
Year:
2024
Meeting:
Second meeting of the Ad Hoc Open-ended Working Group on Benefit-sharing from the Use of Digital Sequence Information on Genetic Resources
Location:
Montreal, Canada
Meeting dates:
12–16 August 2024
Agenda item:
Item 3
Governing framework:
Convention on Biological Diversity
Related decision:
Decision 15/9
Issuing body:
Secretariat of the Convention on Biological Diversity
Type of document:
Executive summary
Commissioning authority:
Conference of the Parties
Partner organizations:
United Nations Environment Programme World Conservation Monitoring Centre; KPMG UK
Funding support:
Government of Norway; Government of the United Kingdom of Great Britain and Northern Ireland; European Commission
Subject:
Multilateral mechanism for benefit-sharing from the use of digital sequence information on genetic resources
Scope:
Criteria for fair and equitable benefit-sharing; revenue-generating measures; global fund
Methodology:
Literature review; semi-structured interviews; stakeholder survey; peer review
Market sectors covered:
Pharmaceutical; cosmetics; plant and animal breeding and agricultural biotechnology; laboratory equipment; information, scientific and technical services related to digital sequence information
Source type:
Intergovernmental meeting document presenting synthesized study findings